On Sep, 2019, Virginia Contract Research Organization Co., Ltd. (VCRO) successfully obtained a permit from the US FDA to carry out a multi-tasked, phase I/IIa trial for a new botanic drug with dermotology use.
Congratulations! VCRO obtained a clinical-go from the US FDA to launch the Phase I/IIa clinical trial of a botanic drugs!
On Sep, 2019, Virginia Contract Research Organization Co., Ltd. (VCRO) successfully obtained a permit from the US FDA to carry out a multi-tasked, phase I/IIa trial for a new botanic drug with dermotology use.